Results 281 to 287 of about 30,003 (287)
Some of the next articles are maybe not open access.
Expert Opinion on Biological Therapy, 2012
Until now most insulin used in developed countries is manufactured and distributed by a small number of multinational companies. Other pharmaceutical companies - many of these are located in countries such as India or China - are also able to manufacture insulin with modern biotechnological methods.
openaire +2 more sources
Until now most insulin used in developed countries is manufactured and distributed by a small number of multinational companies. Other pharmaceutical companies - many of these are located in countries such as India or China - are also able to manufacture insulin with modern biotechnological methods.
openaire +2 more sources
2018
The generic pharmaceutical industry is arguably the most important player in the quest for affordable healthcare, especially in the United States. Since the inception of the industry following the enactment of the Drug Price Competition and Patent Term Restoration Act in 1984, generics have grown by leaps and bounds, and by 2015 they accounted for ...
Z. John Lu, Stuart O. Schweitzer
openaire +1 more source
The generic pharmaceutical industry is arguably the most important player in the quest for affordable healthcare, especially in the United States. Since the inception of the industry following the enactment of the Drug Price Competition and Patent Term Restoration Act in 1984, generics have grown by leaps and bounds, and by 2015 they accounted for ...
Z. John Lu, Stuart O. Schweitzer
openaire +1 more source
Biosimilar anti-VEGF—Yardsticks to ensure biosimilarity
Eye, 2022Ashish Sharma +4 more
openaire +3 more sources
The Disappointment of the Biosimilar
Journal of Law, Medicine & Ethics, 2018openaire +3 more sources
Assessing biosimilarity and interchangeability of biosimilar products
Statistics in Medicine, 2013openaire +2 more sources